CMEology

Overview

With over 25 years in developing continuing education activities, we know how to engage health care providers. At CMEology, our ideas begin and end with the patient. Our activities embrace the National Quality Strategy and are designed to improve the effectiveness of patient care. We strive to provide meaningful learning experiences that inspire and empower. Our outcomes include quantitative assessments with descriptive statistics and subgroup analyses, qualitative results, and outcomes impact analysis and modeling.


Advancing Standards in the Management of Hemophilia A: Contemporary Strategies and Innovations

The US health care ecosystem has undergone a profound transformation in recent years, with far-reaching implications for patients with hemophilia A. Clinical management of patients with hemophilia has become increasingly complex due to the introduction of new treatment strategies, the presence of comorbidities related to hemophilia, and the increased emphasis on outcomes such as quality of life,...
CMEology

Bipolar Disorder in Children and Adolescents: Diagnostic Strategies and New Evidence

One of the most challenging areas of psychiatry is the diagnosis and management of children and adolescents with bipolar spectrum disorders. In particular, treatment of the depressive phase of the bipolar spectrum disorders in children and adolescents remains a largely unmet need. Up to 2 million children in the United States have bipolar disorder. It is now recognized that about half of adult p...
CMEology

Evolving Strategies in the Diagnosis and Management of Autosomal Dominant Polycystic Kidney Disease

Hear from Dr. Arlene Chapman, Professor of Medicine at the University of Chicago and one of the leading experts in autosomal dominant polycystic kidney disease (ADPKD), in this multimedia text article which features videos with expert commentary and animated slides with narration. A case study approach is used to illustrate the latest advancements in the diagnosis and treatment of this rare dise...
CMEology

Getting to Remission: Differentiating Residual Symptoms from Treatment Side Effects in Major Depressive Disorder

Millions of US adults with MDD are inadequately treated despite the availability of effective therapies. Achieving and maintaining remission continues to be a considerable clinical challenge. In addition, cognitive impairment is a common residual symptom, and many clinicians are failing to assess for and manage this aspect of depression. Some residual symptoms, such as weight gain, sleep disturb...
CMEology

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.